ID
33359
Descrição
Study ID: 106837 Clinical Study ID: HZA106837 Study Title: A Long-Term, Randomized, Double-Blind, Parallel Group Study of Fluticasone Furoate/GW642444 Inhalation Powder Once-Daily and Fluticasone Furoate Inhalation Powder Once-Daily in Subjects with Asthma Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01086384 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: fluticasone furoate/vilanterol Trade Name: Relvar Study Indication: Asthma
Palavras-chave
Versões (2)
- 05/11/2018 05/11/2018 -
- 06/12/2018 06/12/2018 -
Titular dos direitos
GSK group of companies
Transferido a
6 de dezembro de 2018
DOI
Para um pedido faça login.
Licença
Creative Commons BY-NC 3.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
A Parallel Group Study of Fluticasone Furoate/Vilanterol in Subjects with Asthma - 106837
Randomisation Criteria List
- StudyEvent: ODM
Descrição
If NO, please select all boxes corresponding to violations of any randomisation criteria
Alias
- UMLS CUI-1
- C0034656
- UMLS CUI-2
- C0243161
- UMLS CUI-3
- C1709750
Descrição
Inclusion
Alias
- UMLS CUI-1
- C1512693
Descrição
1. Evening pre-dose of FEV1 50% to 90% of the predicted normal
Tipo de dados
boolean
Alias
- UMLS CUI [1,1]
- C0439565
- UMLS CUI [1,2]
- C0587117
- UMLS CUI [1,3]
- C0748133
- UMLS CUI [1,4]
- C0205307
Descrição
2. A documented use of albuterol/salbutamol and/or asthma symptoms on at least 3 of the last 7 consecutive days of the run-in period
Tipo de dados
boolean
Alias
- UMLS CUI [1,1]
- C0001927
- UMLS CUI [1,2]
- C0004096
- UMLS CUI [1,3]
- C1457887
Descrição
Exclusion Criteria
Alias
- UMLS CUI-1
- C0680251
Descrição
1. Clinically significant abnormal laboratory tests during Visit 1, which are still abnormal upon repeat analysis and are not believed to be due to disease(s) present. Each investigator will use his/her discretion in determining the clinical significance of the abnormality. When in doubt, GSK, or designee should be notified so that a joint decision can be made.
Tipo de dados
boolean
Alias
- UMLS CUI [1,1]
- C0438215
- UMLS CUI [1,2]
- C2826293
- UMLS CUI [1,3]
- C0545082
- UMLS CUI [2,1]
- C0008961
- UMLS CUI [2,2]
- C0022423
Descrição
2. Changes in asthma medication (excluding albuterol/salbutamol inhalation aerosol provided at Visit 1) occuring between Visits 1 and 2
Tipo de dados
boolean
Alias
- UMLS CUI [1,1]
- C0013227
- UMLS CUI [1,2]
- C0004096
- UMLS CUI [1,3]
- C0392747
- UMLS CUI [2,1]
- C0001927
- UMLS CUI [2,2]
- C0205535
- UMLS CUI [2,3]
- C0001712
- UMLS CUI [3]
- C0545082
Descrição
3. Occurrence of a culture-documented or suspected bacterial or viral infection of the upper or lower respiratory tract, sinus or middle ear during the run-in period that led to a change in asthma management, or, in the opinion of the investigator, is expected to affect the subjects asthma status or the subjects ability to participate in the study
Tipo de dados
boolean
Alias
- UMLS CUI [1,1]
- C2745955
- UMLS CUI [1,2]
- C0004623
- UMLS CUI [2,1]
- C2745955
- UMLS CUI [2,2]
- C0042769
- UMLS CUI [3]
- C0041912
- UMLS CUI [4]
- C0149725
- UMLS CUI [5,1]
- C0008961
- UMLS CUI [5,2]
- C0871010
- UMLS CUI [6,1]
- C0004096
- UMLS CUI [6,2]
- C0449438
- UMLS CUI [7,1]
- C0085732
- UMLS CUI [7,2]
- C2348568
Descrição
If a subject experiences a severe asthma exacerbation during run-in , they may extend the run-in period to recover from the symptoms and wash-out any prohibited medications.
Tipo de dados
boolean
Alias
- UMLS CUI [1]
- C0349790
- UMLS CUI [2]
- C0019993
- UMLS CUI [3,1]
- C3840745
- UMLS CUI [3,2]
- C0545082
Descrição
5. Evidence of significant abnormality in the 12-lead ECG performed at Visit 1, as judged by the investigator. Selected specific ECG findings that are considered to be significant and will exclude the subject from study participation include, but are not limited to, the following:
Tipo de dados
text
Alias
- UMLS CUI [1,1]
- C0430456
- UMLS CUI [1,2]
- C1704258
- UMLS CUI [2]
- C0545082
- UMLS CUI [3,1]
- C0008961
- UMLS CUI [3,2]
- C0022423
- UMLS CUI [4]
- C2348568
Similar models
Randomisation Criteria List
- StudyEvent: ODM
C0243161 (UMLS CUI-2)
C0243161 (UMLS CUI [1,2])
C0243161 (UMLS CUI-2)
C1709750 (UMLS CUI-3)
C0587117 (UMLS CUI [1,2])
C0748133 (UMLS CUI [1,3])
C0205307 (UMLS CUI [1,4])
C0004096 (UMLS CUI [1,2])
C1457887 (UMLS CUI [1,3])
C2826293 (UMLS CUI [1,2])
C0545082 (UMLS CUI [1,3])
C0008961 (UMLS CUI [2,1])
C0022423 (UMLS CUI [2,2])
C0004096 (UMLS CUI [1,2])
C0392747 (UMLS CUI [1,3])
C0001927 (UMLS CUI [2,1])
C0205535 (UMLS CUI [2,2])
C0001712 (UMLS CUI [2,3])
C0545082 (UMLS CUI [3])
C0004623 (UMLS CUI [1,2])
C2745955 (UMLS CUI [2,1])
C0042769 (UMLS CUI [2,2])
C0041912 (UMLS CUI [3])
C0149725 (UMLS CUI [4])
C0008961 (UMLS CUI [5,1])
C0871010 (UMLS CUI [5,2])
C0004096 (UMLS CUI [6,1])
C0449438 (UMLS CUI [6,2])
C0085732 (UMLS CUI [7,1])
C2348568 (UMLS CUI [7,2])
C0019993 (UMLS CUI [2])
C3840745 (UMLS CUI [3,1])
C0545082 (UMLS CUI [3,2])
C1704258 (UMLS CUI [1,2])
C0545082 (UMLS CUI [2])
C0008961 (UMLS CUI [3,1])
C0022423 (UMLS CUI [3,2])
C2348568 (UMLS CUI [4])